D'Alessandro Danilo 4

What Happened

• Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro, had 4,145 restricted stock units (RSUs) settle into common shares on March 11, 2026. Per the filing, 2,109 of those shares were delivered back to ClearPoint to satisfy tax withholding at $11.62 per share, totaling $24,507. The net result was 2,036 shares issued to D'Alessandro.
• This transaction is the routine vesting/settlement of awards (not an open-market buy or discretionary sale). The RSU settlement is reported as a conversion/exercise of a derivative (transaction code M) with tax withholding reported under code F.

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (timely filing).
• Gross shares settled: 4,145 RSUs; shares withheld for taxes: 2,109 at $11.62/share = $24,507; net shares issued to insider: 2,036.
• Footnotes: F1 = RSUs settled into shares on scheduled vesting; F2 = shares delivered to company to satisfy tax withholding.
• Shares owned after the transaction: not specified in the excerpt of the filing.

Context

• This was an RSU vesting/settlement event, not a market purchase or sale. The withholding of shares to cover taxes is a common, routine administrative step and does not necessarily indicate a change in insider sentiment.
• Transaction codes: M indicates conversion/exercise of a derivative (here, RSU settlement); F indicates delivery of shares to cover tax liability (cashless withholding).